Literature DB >> 9001295

Aerodynamic properties of the major dog allergen Can f 1: distribution in homes, concentration, and particle size of allergen in the air.

A Custovic1, R Green, A Fletcher, A Smith, C A Pickering, M D Chapman, A Woodcock.   

Abstract

Exposure and sensitization to dog allergen is a significant cause of asthma. In this study we investigated the distribution, aerodynamic characteristics, and particle-size distribution of the major dog allergen Can f 1. Dust samples were collected in 50 homes with a dog and 50 homes without dogs. Airborne Can f 1 concentration was measured in 28 homes with dogs and 36 homes without a dog. Particle-size distribution was determined by using 10 separate Andersen sampler measurements in a dog-handling facility, and in 10 homes with dogs, and by repeated measurements in a home with one dog. High levels of Can f 1 (> 10 microg/g) were found in dust in all but one home with a dog and in eight of 50 homes without dogs. Airborne Can f 1 levels varied greatly between the homes with dogs (range: 0.3 to 99 ng/m3). Low levels of airborne Can f 1 (range: 0.4 to 1.1 ng/m3) were detected in 11 of 36 homes without a dog. Can f 1 was predominantly associated with large particles collected on the first stage of the Andersen sampler (> 9 microm), which averaged 42 to 49% of the total allergen recovered in the dog-handling facility and in homes with dogs. Small particles (< 5 microm diameter) also carried Can f 1, and these particles comprised approximately 20% of the total airborne allergen load. There was an excellent concordance between the results obtained in different sampling areas, and between the total Can f 1 recovered on the Andersen sampler and on the parallel filter. In conclusion, airborne Can f 1 was detectable in undisturbed conditions in all homes with dogs and in almost one third of the homes without dogs. In houses with dogs, a significant proportion (approximately 20%) of airborne Can f 1 was associated with small particles (< 5 microm diameter). Owing to their aerodynamic characteristics, these particles would be expected to remain airborne for a long period and, when inhaled, could penetrate into the lower airways and initiate asthma attacks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9001295     DOI: 10.1164/ajrccm.155.1.9001295

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

Review 1.  Immunoassays for indoor allergens.

Authors:  M D Chapman; L D Vailes; K Ichikawa
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

Review 2.  Monitoring personal allergen exposure.

Authors:  T O'Meara; E Tovey
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

Review 3.  New approaches to environmental control.

Authors:  J W Vaughan; T A Platts-Mills
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

Review 4.  Indoor Environmental Interventions for Furry Pet Allergens, Pest Allergens, and Mold: Looking to the Future.

Authors:  Sharon K Ahluwalia; Elizabeth C Matsui
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb

Review 5.  Sampling Devices for Indoor Allergen Exposure: Pros and Cons.

Authors:  Torie Grant; Ana M Rule; Kirsten Koehler; Robert A Wood; Elizabeth C Matsui
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-12       Impact factor: 4.806

6.  Performance of the halogen immunoassay to assess airborne mouse allergen-containing particles in a laboratory animal facility.

Authors:  Félix E Rivera-Mariani; Elizabeth C Matsui; Patrick N Breysse
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-07-18       Impact factor: 5.563

7.  Validation of a novel sampling technology for airborne allergens in low-income urban homes.

Authors:  Julian Gordon; Rachel Reboulet; Prasanthi Gandhi; Elizabeth Matsui
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

8.  Prevention of atopic disorders.

Authors:  Lata Kumar; Pinki Surana
Journal:  Indian J Pediatr       Date:  2002-03       Impact factor: 1.967

9.  Fel d 1-airway inflammation prevention and treatment by co-immunization vaccine via induction of CD4+CD25-Foxp3+ Treg cells.

Authors:  Yechun Pei; Shuang Geng; Lin Liu; Fengxiang Yan; Hong Guan; Jian Hou; Yongfu Chen; Bin Wang; Xiaorong An
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

10.  Parent report of pests and pets and indoor allergen levels in inner-city homes.

Authors:  Jean Curtin-Brosnan; Elizabeth C Matsui; Patrick Breysse; Meredith C McCormack; Nadia N Hansel; Emily S Tonorezos; Peyton A Eggleston; Dann L Williams; Gregory B Diette
Journal:  Ann Allergy Asthma Immunol       Date:  2008-11       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.